Which cancer type has the highest risk of COVID-19 infection?
Changjing Cai(Central South University), Shan Zeng(Central South University)
Cited by 19
Related Papers
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
|The Lancet Haematology|2019|248
Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice
|Hepatology|2004|177
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
|Molecular Cancer|2025|98